-The board has approved a strategic review of the biotech assets and ALT5 Sigma being the core focus going forward-

-The company is intending a name and stock symbol change to reflect this decision-

LAS VEGAS, July 10, 2024 /PRNewswire/ -- JanOne Inc. (Nasdaq: JAN), a multidisciplinary organization with a focus on fintech and healthcare, has...